Compass Pathways Plc (CMPS)
8.10
-0.55
(-6.36%)
USD |
NASDAQ |
Nov 20, 10:47
Compass Pathways Free Cash Flow : -176.69M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -176.69M |
| June 30, 2026 | -160.76M |
| March 31, 2026 | -159.63M |
| December 31, 2025 | -157.61M |
| September 30, 2025 | -161.34M |
| June 30, 2025 | -149.05M |
| March 31, 2025 | -144.25M |
| December 31, 2024 | -119.24M |
| September 30, 2024 | -105.63M |
| June 30, 2024 | -101.13M |
| March 31, 2024 | -91.11M |
| December 31, 2023 | -97.82M |
| Date | Value |
|---|---|
| September 30, 2023 | -115.41M |
| June 30, 2023 | -114.49M |
| March 31, 2023 | -108.35M |
| December 31, 2022 | -103.90M |
| September 30, 2022 | -80.81M |
| June 30, 2022 | -77.78M |
| March 31, 2022 | -77.25M |
| December 31, 2021 | -68.07M |
| September 30, 2021 | -62.50M |
| June 30, 2021 | -62.36M |
| March 31, 2021 | -50.90M |
| December 31, 2020 | -41.51M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Silence Therapeutics Plc | -43.51M |
| Biodexa Pharmaceuticals Plc | -10.63M |
| NuCana Plc | -10.23M |
| Mereo BioPharma Group Plc | -22.37M |
| HemoGenyx Pharmaceuticals Plc | -1.937M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -50.74M |
| Cash from Financing (Quarterly) | 63.01M |
| Free Cash Flow Per Share (Quarterly) | -0.3121 |
| Free Cash Flow to Equity (Quarterly) | -50.50M |
| Free Cash Flow to Firm (Quarterly) | -49.60M |
| Free Cash Flow Yield | -15.40% |